Russia Temporarily Authorizes Use of Avigan Against Covid 19

0 66

Get real time updates directly on you device, subscribe now.

Avifavir, developed by a joint venture of the Russian Direct Investment Fund and ChemRar Group, is designed to disrupt the novel coronavirus’s ability to reproduce and has proven effective in clinical trials. A researcher sounded a note of caution while the head of the wealth fund said it’s a potential breakthrough.

Reference

YOU MIGHT ALSO LIKE

In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.

DAILY NEW CASES AND DEATHS IN US, CDC SITE

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy